October 2019

With the Opioid Epidemic, Communities See Dramatic Increases in Infectious Diseases

October 17, 2019

Feature - Emerging & Re-Emerging Infections

Rising incidence of viral and bacterial infections has accompanied the opioid crisis, but it also presents new opportunities for multidisciplinary treatment and preventive care.

Evaluating the Role of New Beta-Lactam Agents for Uncommon Pathogens

October 14, 2019

Multidrug-Resistant Infections

Novel β-lactam/β-lactamase inhibitor combinations and cefiderocol may play a part in the treatment of infections caused by Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and Burkholderia cepacia complex.

Where to Treat Uncomplicated HCV? Assessing the Impact of Shifting Care From Specialists to PCPs

October 08, 2019

In the Literature

One promising proposal to greatly increase access to DAA HCV therapy is to keep this treatment with appropriately trained PCPs, in contrast with referring patients to infectious disease, gastroenterology, or hepatology subspecialists.

Same-Day PrEP Initiation: Simplifying Access and Dismantling Barriers to Care

October 07, 2019

In the Literature

Unsurprisingly, STD clinics have reported increased patient interest in PrEP; however, these clinics often face challenges in providing longitudinal patient care because of limited resources and capacity.